Resources
120 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 5/17/2024
The Alcohol-Related Disease Impact (ARDI) is an online application from the Centers for Disease Control and Prevention (CDC) that provides national and state estimates of alcohol-related health impacts, including deaths and years of potential life lost (YPLL).
Posted 4/26/2024
The Nitazenes Overview resource created by RCORP-TA describes what nitazenes are, how to determine if they are in your community, and how to prevent and respond to overdoses due to nitazenes. Additional resources are also provided to learn more about nitazenes.
Posted 4/15/2024 (updated 5/23/2024)
The 2024 RCORP Data Coordinator meeting series began in May 2024, hosted by RCORP-Evaluation (Customer Value Partners), in partnership with RCORP-TA (JBS International). The purpose of this meeting series is to present a deep dive into all aspects of PIMS data collection with an overview of data requirements, data collection, and addressing common data collection challenges with hands-on best practices. This series is geared towards Data Coordinators; however, anyone involved in RCORP grant data collection is welcome to join. You can find slides, recordings, and materials from the meetings linked below.
Posted 3/29/2024 (updated 4/4/2024)
Posted 3/29/2024 (updated 4/4/2024)
Posted 3/29/2024 (updated 4/4/2024)
During this session, participants planned to learn how to build trust and break down barriers with hard to reach populations.
Posted 3/22/2024 (updated 3/28/2024)
The RCORP-Evaluation Team hosted this webinar overview of the March 2024 PIMS data submission on February 29, 2024. The webinar was presented by the Data Capacity Building Lead, Nitika Jain, MPH, PhD(c), and the Project Manager, Sarah Lifsey, MPP, PMP.
Posted 2/23/2024 (updated 3/28/2024)
his study assessed the degree in which health care professionals who were practicing within primary care or were likely to come in contact with patients with opioid use disorder (OUD) were endorsing misinformation about buprenorphine and if this affected their willingness to care for patients with OUD.
Posted 2/2/2024 (updated 3/28/2024)
The National Academy for State Health Policy provides information on why and how to include people with lived experience in opioid settlement decision-making.
Posted 2/2/2024 (updated 3/28/2024)
The U.S. Department of Health and Human Services' Office of Minority Health provided a brief in November 2023 assessing whether and how rates of substance use and substance use disorder (SUD) among adults (ages 18 and older) differ by race and ethnicity.